Multi-epitopic vaccine
US9187534B2 · kind B2 · utility
5Cited by
0References
14Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 9, 2012 |
| Grant date | Nov 17, 2015 |
| Priority date | — |
| Expiry date | May 19, 2032 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to isolated polypeptides comprising: (i) a protein transduction domain consisting of ZEBRA or a fragment thereof that retains the capacity of internalization, (ii) at least one CD4+ epitope; and (iii) at least one CD8+ epitope. It also relates to antigen presenting cells loaded with said polypeptides, and the use thereof in immunotherapy including prevention and/or treatment of cancers or infectious diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.